Effect of Ginkgo biloba Extract Ingestion on Plasma Total Cortisol Levels during an Oral Glucose Tolerance Test in Normal Glucose Tolerant Individuals: Recent Study
Protracted periods of increased cortisol production, as may be seen in acute illness, may lead to transient hyperglycemia. Increasing evidence suggests that cortisol may then mediate insulin resistance and potentially lead to the development of diabetes. Evidence in animal studies also suggests that under conditions of stress Ginkgo biloba extract could reduce plasma cortisol production and so the primary aim of this study was to determine the effect of Ginkgo biloba extract ingestion on plasma cortisol production during an acute period of glucose challenge. Healthy normal glucose tolerant subjects (n=30, (10/20, M/F); age, 45.79.9 years old) completed a randomized, double-blind, placebo-controlled crossover study when they ingested Ginkgo biloba extract (120 mg/day as a single dose) or placebo during each 3-month arm. A standard 75 g oral glucose tolerance test was performed at the end of each cycle and blood was collected and used to measure plasma glucose, insulin, c-peptide and cortisol. Fasting plasma cortisol was significantly lower after the Ginkgo biloba cycle than the placebo cycle (9.74.4 vs. 11.85.4 g/dl, respectively; p<0.05). The plasma cortisol area under the curve during the 2-hour test (AUC0-2) was also significantly lower after ingestion of the Ginkgo biloba cycle compared to the placebo (19.27.7 vs. 24.14.9 μg/dl/h, respectively; p<0.001). It is concluded that the ingestion of Ginkgo biloba extract has effect on the hypothalamic-pituitary-adrenal axis leading to reduced basal cortisol levels and reduced cortisol production in response to acute hyperglycemic challenge.
Dr. George B. Kudolo
Department of Health Sciences, Division of Medical Laboratory Sciences, School of Health Professions, University of Texas Health Science Center at San Antonio, Texas, USA.
View Book :- http://bp.bookpi.org/index.php/bpi/catalog/book/203